{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:38:11Z","timestamp":1792269491663,"version":"4.4.0"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Clozapine is highly effective for treatment-resistant schizophrenia, schizoaffective disorder, and treatment-resistant mania. However, it is associated with significant inflammatory adverse effects, including fever and severe organ involvement such as myocarditis, pneumonia, and enteritis. Close serial monitoring of inflammatory markers (white blood cell count, C-reactive protein, and neutrophils) combined with individualized, slow dose titration is essential to minimize these risks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case report<\/jats:title>\n                    <jats:p>We describe a 21-year-old Chinese male with treatment-resistant mania who developed fever, pulmonary inflammation, myalgia, nausea, vomiting, abdominal distension, leukocytosis with neutrophilia, and elevated C-reactive protein during the initial rapid titration of clozapine. The inflammatory response resolved promptly after dose reduction and did not recur with a slower titration schedule and lower maintenance dose.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This case highlights the importance of vigilant monitoring of inflammatory markers during clozapine initiation and supports the use of personalized titration regimens, particularly in East Asian populations who may be at heightened risk of clozapine-induced inflammation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2026.1886320","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:51:22Z","timestamp":1787921482000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Clozapine-induced inflammation: a case report"],"prefix":"10.3389","volume":"17","author":[{"given":"Tian","family":"Han","sequence":"first","affiliation":[{"name":"Beijing Key Laboratory of Intelligent Drug Research and Development for Mental Disorders & National Clinical Research Center for Mental Disorders & National Center for Mental Disorders & Beijing Anding Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iunan","family":"Lin","sequence":"additional","affiliation":[{"name":"Beijing Key Laboratory of Intelligent Drug Research and Development for Mental Disorders & National Clinical Research Center for Mental Disorders & National Center for Mental Disorders & Beijing Anding Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ji","sequence":"additional","affiliation":[{"name":"Beijing Key Laboratory of Intelligent Drug Research and Development for Mental Disorders & National Clinical Research Center for Mental Disorders & National Center for Mental Disorders & Beijing Anding Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12272","article-title":"Clozapine for treatment-resistant bipolar disorder: a systematic review","volume":"17","author":"Li","year":"2015","journal-title":"Bipolar Disord"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2009.00672.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2020.02.026","article-title":"Clozapine in bipolar disorder: A systematic review and meta-analysis","volume":"125","author":"Delgado","year":"2020","journal-title":"J Psychiatr Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2023.10.027","article-title":"Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database","volume":"268","author":"de Filippis","year":"2024","journal-title":"Schizophr Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2026.1806564","article-title":"Longitudinal trends in blood concentrations of clozapine and norclozapine, inflammatory markers, and clinical outcomes in Japanese patients: a 12-week prospective study","volume":"17","author":"Nakamura","year":"2026","journal-title":"Front Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2023.513","article-title":"Clozapine and Sweet's syndrome: case report","volume":"9","author":"Bunting","year":"2023","journal-title":"BJPsych Open"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1017\/ipm.2019.24","article-title":"Clozapine-induced interstitial nephritis in a patient with schizoaffective disorder in the forensic setting: a case report and review of the literature","volume":"39","author":"McLoughlin","year":"2022","journal-title":"Ir J Psychol Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2023-259154","article-title":"Clozapine-induced pneumonitis mimicking an atypical pneumonia","volume":"17","author":"Vaselli","year":"2024","journal-title":"BMJ Case Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfab154","article-title":"Clozapine induces an acute proinflammatory response that is attenuated by inhibition of inflammasome signaling: Implications for idiosyncratic drug-induced agranulocytosis","volume":"186","author":"Sernoskie","year":"2022","journal-title":"Toxicol Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.24869\/psyd.2022.411","article-title":"Reflections on the complex history of the concept of clozapine-induced inflammation during titration","volume":"34","author":"de Leon","year":"2022","journal-title":"Psychiatr Danub"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/gpsych-2019-100183","article-title":"Clozapine is strongly associated with the risk of pneumonia and inflammation","volume":"33","author":"de Leon","year":"2020","journal-title":"Gen Psychiatr"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/0091217417749799","article-title":"Two cases of high serum clozapine concentrations occurring during inflammation in Chinese patients","volume":"53","author":"Ruan","year":"2018","journal-title":"Int J Psychiatry Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbag087","article-title":"Clozapine-associated neutropenia among people on clozapine in Japan: a nationally representative retrospective cohort study","volume":"52","author":"Trott","year":"2026","journal-title":"Schizophr Bull"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyw109","article-title":"The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 3: The Clinical Guidelines","volume":"20","author":"Fountoulakis","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-025-01236-x","article-title":"Ethnicity-based personalized clozapine titration strategies for prevention of clozapine-induced inflammation: recommendations based on evidence from the Japanese population","volume":"40","author":"Kikuchi","year":"2026","journal-title":"CNS Drugs"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2018.152","article-title":"Clozapine is associated with secondary antibody deficiency","volume":"214","author":"Ponsford","year":"2019","journal-title":"Br J Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1366621","article-title":"Patterns of C-reactive protein trends during clozapine titration and the onset of clozapine-induced inflammation: a case series of weekly and daily C-reactive protein monitoring","volume":"15","author":"Kikuchi","year":"2024","journal-title":"Front Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2012.08.018","article-title":"Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: a case-control study","volume":"141","author":"Ronaldson","year":"2012","journal-title":"Schizophr Res"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1886320\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:51:23Z","timestamp":1787921483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1886320\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":18,"alternative-id":["10.3389\/fpsyt.2026.1886320"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1886320","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"article-number":"1886320"}}